Health

A scientific breakthrough may lead to an effective anti-obesity drug

Chopra along with his team first discovered asprosin in 2016, almost by accident. They were studying neonatal progeroid syndrome, a genetic disorder in which people are extremely thin, along with found which, compared to people without the syndrome, people who had the idea were severely lacking in a previously unknown hormone they termed asprosin. from the brand new study, published ...

Read More »

Military veterans fight for medical marijuana to kick opioid addiction

The fight for medical in addition to recreational marijuana has long stood counter to traditional conservative values. although as more veterans advocate for medical cannabis, the dynamic will be shifting. Krawitz believes his dad, a “real conservative World War II vet,” might support medical marijuana. As the opioid crisis worsens for veterans, coupled which has a veteran suicide rate which ...

Read More »

Gilead fourth-quarter hepatitis C drug sales plummet; company sees a further slowdown

Gilead Sciences on Tuesday said fourth-quarter sales of its flagship hepatitis C drugs fell by more than half amid increased competition, as well as the company forecast a further slowdown for the current year. Gilead’s shares fell slightly after the closing bell. For full-year 2018, the biotechnology company forecast product sales of $20 billion to $21 billion — including hepatitis ...

Read More »

Express Scripts plans see lower gains in prescription drug spending

Prescription drug prices may still be high, yet Express Scripts says the commercial insurance plans which works with saw the lowest increase in drug spending last year in nearly a quarter of a century. For private employer as well as individual health plans, total drug spending rose 1.5 percent last year, according to the latest Express Scripts annual Drug Trend ...

Read More »

Allergan earnings Q4 2017 beat estimates, says migraine trial succeeds

Allergan on Tuesday smashed expectations for fourth-quarter adjusted earnings along with said the first of two key trials for its migraine treatment was successful. Here’s how the company did compared with what Wall Street expected: EPS: $4.86 vs. Thomson Reuters’ survey projection of $4.74. Revenue: $4.33 billion vs. Thomson Reuters’ $4.28 billion estimate. inside the fourth quarter, the pharmaceutical company ...

Read More »

Stephen Friend leaves Apple Health

Stephen Friend will be out at Apple’s health team, after just over a year at the company, according to people familiar with the matter. Friend’s specialty involves rethinking health care research, that has a focus on creating open incentives in addition to also also standards which benefit patients. which was the mission of Sage Bionetworks, a non-profit which he co-founded ...

Read More »